Thursday, September 22, 2011

Merck Accelerates Layoffs; VA Halts Roche's Avastin for Eyes - Sept. 22, 2011

Having trouble viewing this email? View in Browser.
BioSpace GenePool
   Thursday, September 22, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

At Aptuit's MHRA certified and FDA inspected multi-purpose manufacturing site in Oxford, England, we can produce highly potent compounds at commercial scale in accordance with the highest safety and quality standards.

Please click here for more information.
Top Stories 
•  Merck & Co., Inc. (MRK) Accelerates Layoffs More...
•  VA Halts Roche (RHHBY)'s Avastin for Eyes More...
•  Bristol-Myers Squibb Company (BMY) and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure More...
•  GlaxoSmithKline (GSK) Weighs Rival Sites for New Plant, Plant Would Create Up to 500 Jobs More...
•  Loxbridge and Dr Kary Mullis Announce the Formation of Altermune Technologies with $7 Million Seed Investment More...
•  New Research Challenges Sirtris Pharmaceuticals (SIRT)'s Longevity Gene Findings More...
•  Eli Lilly and Company (LLY) Steps Up Efforts to Improve Diversity in Clinical Trials More...
•  Servier Founder Ensnared in Mediator Scandal; Charged in Deaths and Granted 4 Million Euro Bail More...

More Top News
Don't Miss This

Scottish Development International:

The home of whisky and the bionic hand, we're the toast of the scientific community.

Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project.

Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness.

Click here to learn more about Scotland as the ideal location for your business.
Featured Stories
•  Medicis (MRX) CEO Wants Deaths Investigated More...
•  Calls for Europe to Curb and Control Off-Label Use More...
•  Do Women's Voices Really Allow Men to Detect Ovulation? Roehampton University and Tel Aviv University Study More...
•  Gene Helps Explain a Third of Inherited ALS Cases, Mayo Clinic Study More...
•  Researchers Create First Human Heart Cells That Can Be Paced With Light, Stanford University Study More...
•  New Twist in a Blindness-Causing Disease Gene Found, University of Pennsylvania Study More...
•  Lung Cancer Linked to Risk of Stroke, Harvard School of Public Health Study More...
•  Could Divorce Trigger Hair Loss in Women? Case Western Reserve University Study More...
Tower: Facebook

 
More Featured News
Event of the day

Social & Scientific Systems, Inc., and panel members, Eleanor Feingold, Gina D'Angelo, and Joan Bailey-Wilson, invite you to join us at a symposium to honor Brad Efron for his many contributions to theoretical and applied statistics. We will be discussing emerging statistical challenges in large-scale inference, with a focus on applications in genetics and biomedical imaging. The goal of the symposium is to stimulate discussion; it will include both formal and informal meeting and discussion time, in addition to the featured speakers.

The symposium is limited to 200 people. Please RSVP to: LargeData@s-3.com.

Please click here for more information.
Latest Market Insight

Product Profiles: Colorectal Cancer - New drug combinations and label expansions will increase competition

• Analysis of marketed colorectal cancer drugs - development history, key clinical trial data, and assessment of clinical and commercial attractiveness.
• Analysis of marketed drugs in comparison to current standard of care.
• In-depth analysis of late-stage pipeline drugs - development overview, SWOT analysis, and assessment of clinical and commercial attractiveness.
• Discussion and assessment of pipeline drugs' ability to meet unmet needs in treatment of colorectal cancer.

Click Here for More Information


Featured Free Resource

Drug Discovery & Development

Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers

Request Now!
Top Jobs
Biotech Beach (San Diego, California)

Helicon Therapeutics, Inc.
Research Associate/Associate Scientist, Neuropharmacology
Will be responsible for the execution of in vivo rodent experiments to evaluate the primary pharmacology of novel compounds that enhance cognition. Candidates will also be responsible for data analysis including statistical analysis and data presentation.

SuisseBio (Basel, Switzerland)

Novartis Institutes for BioMedical Research, Inc.
Global Head Safety Pharmacology (Director/Executive Director)
Will lead the overall Safety Pharmacology function in Preclinical Safety at Novartis, including responsibility for quality, timeliness and availability of the appropriate resources for internal decision making regarding risk and for satisfaction of regulatory expectations.

Rocky Bio (Salt Lake City, Utah)

Sera Prognostics, Inc.
Director, Clinical Operations
Will be responsible for managing translational medicine studies by interfacing with study sites and contract vendors, while also providing operational and implementation expertise to project teams.

Genetown (Cambridge, Massachusetts)

On Assignment Clinical Research
Statistical Programming Analyst
Serves as the Statistical Programming Lead to achieve milestones on multiple studies across a drug program by evaluating objectives, coordinating and managing statistical programming activities and deliverables, and communicating issues and resource needs to management.

BioTechxus (Houston, Texas)

Baylor College of Medicine
Senior Research Assistant
Will perform primarily yeast and microbial protein expression experiments in a process development environment. In addition this position will expand into insect cell and mammalian cell fermentation expression systems.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

Biotech Pharm Country Career Fair

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, San Diego, CA September 22, 2011
BioMidwest Career Fair, Chicago, IL October 4, 2011
Pharm Country Career Fair, Bridgewater, NJ October 5, 2011
Biotech Bay Career Fair, Burlingame, CA October 11, 2011
Bio NC Career Fair, Durham, NC October 20, 2011
BioCapital Beach Career Fair, Bethesda, MD November 1, 2011
Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Alkermes (Wilmington, Ohio)
265 Olinger Circle
Wilmington, Ohio 45177 U.S.A.
Phone: 937-382-5642 Fax: 937-382-5949

Alkermes, Inc. is a pharmaceutical company leveraging developing sophisticated drug delivery technologies to enhance therapeutic outcomes in major diseases. The Company's lead commercial product, Risperdal® Consta™ [(risperidone) long-acting injection], is the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and is marketed worldwide by Janssen-Cilag ("Janssen"), a wholly owned subsidiary of Johnson & Johnson.

More Company Profiles
Free Resources
FREE Subscription to Drug Discovery & Development

Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products in a way that no other publication can to key decision-makers. Drug Discovery & Development is printed 10 times a year (monthly except bi-monthly in July/Aug and Nov/Dec) and is available in Print or Digital format.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: